Advair Diskus 250/50 (Fluticasone 250 µg and salmeterol 50 µg inhalation powder)

News
Article

Novel therapy for COPD

Newsletter

Get the latest industry news, event updates, and more from Managed healthcare Executive.

Subscribe Now!
Recent Videos
Related Content
FDA Approves Eydenzelt, Additional Eylea Biosimilar

FDA Approves Eydenzelt, Additional Eylea Biosimilar

Logan Lutton
October 11th 2025
Article

Read More

Remote Care Advancement for Heart Failure, COPD and Diabetes Patients

Remote Care Advancement for Heart Failure, COPD and Diabetes Patients

Briana Contreras
October 11th 2025
Podcast

Listen

©keetazalay stock.adobe.com

Researchers in China Develop Tool to Detect Hidden Lung Damage in RA Patients

Keith Loria
October 11th 2025
Article

Read More

David Calabrese of OptumRx Talks Top Three Drugs in Pipeline, Industry Trends in Q2

David Calabrese of OptumRx Talks Top Three Drugs in Pipeline, Industry Trends in Q2

Briana Contreras
October 11th 2025
Podcast

Listen

Lungs in bluish visual suggestive of computing | image credit: ©selvi stock.adobe.com

New Study AI Explores IPF and the Biology of Aging

Keith Loria
October 11th 2025
Article

Read More

IPF in red letters with tablets | image creditt: ©Zhanna stock.adobe.com

PureTech Reports New Data Showing Promise for Deupirfenidone for IPF

Keith Loria
October 11th 2025
Article

Read More

© 2025 MJH Life Sciences

All rights reserved.